Abstract
Examination of the pharmacophoric points of the pyrazolo[1,5-a]pyrimidine derivatives, ligands for BZR, previously published led us to the design of a novel class of 3,6-diaryl-4,7-dihydro-pyrazolo[1,5-a]pyrimidin-7-ones and to determine the groups involved in the BZR recognition.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Affinity Labels / chemical synthesis*
-
Affinity Labels / chemistry
-
Affinity Labels / metabolism*
-
Animals
-
Binding Sites
-
Drug Design
-
GABA-A Receptor Antagonists
-
In Vitro Techniques
-
Kinetics
-
Ligands
-
Models, Molecular
-
Molecular Conformation
-
Pyrazoles / chemical synthesis*
-
Pyrazoles / chemistry
-
Pyrazoles / metabolism*
-
Pyrimidines / chemical synthesis*
-
Pyrimidines / chemistry
-
Pyrimidines / metabolism*
-
Receptors, GABA-A / metabolism*
-
Structure-Activity Relationship
Substances
-
Affinity Labels
-
GABA-A Receptor Antagonists
-
Ligands
-
Pyrazoles
-
Pyrimidines
-
Receptors, GABA-A